These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28103304)

  • 1. Correction: The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys.
    Singh SB; Kang L; Nawrocki AR; Zhou D; Wu M; Previs S; Miller C; Liu H; Hines CD; Madeira M; Cao J; Herath K; Spears LD; Semenkovich CF; Wang L; Kelley DE; Li C; Guan HP
    PLoS One; 2017; 12(1):e0170721. PubMed ID: 28103304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys.
    Singh SB; Kang L; Nawrocki AR; Zhou D; Wu M; Previs S; Miller C; Liu H; Hines CD; Madeira M; Cao J; Herath K; Spears LD; Semenkovich CF; Wang L; Kelley DE; Li C; Guan HP
    PLoS One; 2016; 11(10):e0164133. PubMed ID: 27695056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
    Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
    PLoS One; 2020; 15(7):e0235729. PubMed ID: 32609746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Serum fatty acid-binding protein 4 (FABP4) concentration is associated with insulin resistance in peripheral tissues, A clinical study.
    Nakamura R; Okura T; Fujioka Y; Sumi K; Matsuzawa K; Izawa S; Ueta E; Kato M; Taniguchi SI; Yamamoto K
    PLoS One; 2019; 14(1):e0210932. PubMed ID: 30640959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Hesperidin improves insulin resistance via down-regulation of inflammatory responses: Biochemical analysis and in silico validation.
    Rehman K; Munawar SM; Akash MSH; Buabeid MA; Chohan TA; Tariq M; Jabeen K; Arafa EA
    PLoS One; 2020; 15(2):e0229348. PubMed ID: 32049981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Engineering of Recombinant Poplar Deoxy-D-Xylulose-5-Phosphate Synthase (PtDXS) by Site-Directed Mutagenesis Improves Its Activity.
    Banerjee A; Preiser AL; Sharkey TD
    PLoS One; 2016; 11(10):e0165028. PubMed ID: 27736979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    Lowe PP; Gyongyosi B; Satishchandran A; Iracheta-Vellve A; Ambade A; Cho Y; Kodys K; Catalano D; Ward DV; Szabo G
    PLoS One; 2017; 12(5):e0179070. PubMed ID: 28562651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
    Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
    Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease.
    McMahan RH; Porsche CE; Edwards MG; Rosen HR
    PLoS One; 2016; 11(12):e0168301. PubMed ID: 27930747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice.
    Brachs S; Winkel AF; Polack J; Tang H; Brachs M; Margerie D; Brunner B; Jahn-Hofmann K; Ruetten H; Spranger J; Schmoll D
    PLoS One; 2017; 12(2):e0172657. PubMed ID: 28207865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Preliminary Validation of a High Docosahexaenoic Acid (DHA) and α-Linolenic Acid (ALA) Dietary Oil Blend: Tissue Fatty Acid Composition and Liver Proteome Response in Atlantic Salmon (Salmo salar) Smolts.
    PLOS ONE Staff
    PLoS One; 2018; 13(5):e0197800. PubMed ID: 29771968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Modeling the natural history of fatty liver using lifestyle-related risk factors: Effects of body mass index (BMI) on the life-course of fatty liver.
    Aizawa M; Inagaki S; Moriyama M; Asano K; Kakehashi M
    PLoS One; 2019; 14(12):e0226059. PubMed ID: 31790502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Insulin and diet-induced changes in the ubiquitin-modified proteome of rat liver.
    Nagarajan SR; Brandon AE; McKenna JA; Shtein HC; Nguyen TQ; Suryana E; Poronnik P; Cooney GJ; Saunders DN; Hoy AJ
    PLoS One; 2017; 12(9):e0184610. PubMed ID: 28886158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: The Relationship between Serum Ferritin Levels and Insulin Resistance in Pre- and Postmenopausal Korean Women: KNHANES 2007-2010.
    Kim MK; Chon SJ; Jung YS; Kim BO; Noe EB; Yun BH; Cho S; Choi YS; Lee BS; Seo SK
    PLoS One; 2016; 11(7):e0160300. PubMed ID: 27459205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    Lee J; Yoon K; Ryu S; Chang Y; Kim HR
    PLoS One; 2018; 13(10):e0206834. PubMed ID: 30372496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
    PLOS ONE Staff
    PLoS One; 2019; 14(2):e0212144. PubMed ID: 30721255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platensimycin is a selective FabF inhibitor with potent antibiotic properties.
    Wang J; Soisson SM; Young K; Shoop W; Kodali S; Galgoci A; Painter R; Parthasarathy G; Tang YS; Cummings R; Ha S; Dorso K; Motyl M; Jayasuriya H; Ondeyka J; Herath K; Zhang C; Hernandez L; Allocco J; Basilio A; Tormo JR; Genilloud O; Vicente F; Pelaez F; Colwell L; Lee SH; Michael B; Felcetto T; Gill C; Silver LL; Hermes JD; Bartizal K; Barrett J; Schmatz D; Becker JW; Cully D; Singh SB
    Nature; 2006 May; 441(7091):358-61. PubMed ID: 16710421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.